Bleakley Financial Group’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $716K | Sell |
18,129
-4,155
| -19% | -$164K | 0.02% | 447 |
|
|
2025
Q1 | $672K | Buy |
22,284
+5,342
| +32% | +$161K | 0.02% | 396 |
|
|
2024
Q4 | $592K | Buy |
16,942
+264
| +2% | +$9.23K | 0.02% | 567 |
|
|
2024
Q3 | $668K | Buy |
16,678
+338
| +2% | +$13.5K | 0.02% | 510 |
|
|
2024
Q2 | $779K | Buy |
16,340
+111
| +0.7% | +$5.29K | 0.02% | 478 |
|
|
2024
Q1 | $704K | Buy |
16,229
+3,990
| +33% | +$173K | 0.02% | 519 |
|
|
2023
Q4 | $619K | Buy |
12,239
+41
| +0.3% | +$2.07K | 0.02% | 528 |
|
|
2023
Q3 | $553K | Sell |
12,198
-340
| -3% | -$15.4K | 0.02% | 517 |
|
|
2023
Q2 | $514K | Buy |
12,538
+291
| +2% | +$11.9K | 0.02% | 576 |
|
|
2023
Q1 | $438K | Sell |
12,247
-937
| -7% | -$33.5K | 0.01% | 600 |
|
|
2022
Q4 | $498K | Buy |
+13,184
| New | +$498K | 0.02% | 556 |
|